One-year post-hospital medical costs and relapse rates of bipolar disorder patients in Taiwan: A population-based study

Bipolar Disorders

Volumn 12, Issue 8, 2010, Pages 859-865

  Tang, Chao Hsiun ^a,b   Hsieh, Ming H ^c   Hung, Sheng Tzu ^a   Lee, I Hui ^d   Lin, Yung Jung ^e   Yang, Yen Kuang ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e Janssen Cilag Taiwan   (Taiwan)

Author keywords

Bipolar disorder; Medical costs; Medication possession ratio (MPR); Relapse

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; TAIWAN; TREATMENT REFUSAL;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT DISCHARGE; RECURRENCE; SAMPLING STUDIES; TAIWAN; TIME FACTORS;

EID: 78650556146     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00878.x     Document Type: Article

References (34)

1. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004; 20: 139-154.
2. Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D. Costs of bipolar disorder. Pharmacoeconomics 2003; 21: 601-622.
3. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005; 293: 2528-2530.
4. Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv 1999; 50: 1303-1308.
5. Begley CE, Annegers JF, Swann AC et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001; 19: 483-495.
6. Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry 2003; 160: 1286-1290.
7. Laxman KE, Lovibond KS, Hassan MK. Impact of bipolar disorder in employed populations. Am J Manag Care 2008; 14: 757-764.
8. Otto MW, Simon NM, Wisniewski SR et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006; 189: 20-25.
9. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004; 185: 372-377.
10. Altman S, Haeri S, Cohen LJ et al. Predictors of relapse in bipolar disorder: a review. J Psychiatr Pract 2006; 12: 269-282.
11. Perlick DA, Rosenheck RA, Clarkin JF, Sirey J, Raue P. Symptoms predicting inpatient service use among patients with bipolar affective disorder. Psychiatr Serv 1999; 50: 806-812.
12. Hassan M, Lage MJ. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. Am J Health Syst Pharm 2009; 66: 358-365.
13. Gyulai L, Bauer MS, Marangell LB et al. Correlates of functioning in bipolar disorder. Psychopharmacol Bull 2008; 41: 51-64.
14. Geller B, Craney JL, Bolhofner K, DelBello MP, Williams M, Zimerman B. One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2001; 158: 303-305.
15. Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J Clin Psychiatry 2000; 61: 393-396.
16. Baldassano CF, Marangell LB, Gyulai L et al. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord 2005; 7: 465-470.
17. Kessing LV. Recurrence in affective disorder. II. Effect of age and gender. Br J Psychiatry 1998; 172: 29-34.
18. Lin KM, Cheung F. Mental health issues for Asian Americans. Psychiatr Serv 1999; 50: 774-780.
19. Strakowski SM, Tsai SY, Delbello MP et al. Outcome following a first manic episode: cross-national US and Taiwan comparison. Bipolar Disord 2007; 9: 820-827.
20. National Health Research Institute. Background of National Health Insurance Database. Last accessed October 27, 2010.
21. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-574.
22. McMahon AD, Evans JM, McGilchrist MM, McDevitt DG, MacDonald TM. Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology. Pharmacoepidemiol Drug Saf 1998; 7: 275-280.
23. Taiwan Department of Health. Annual report on expenditure of National Health Insurance in 2006. Last accessed October 27, 2010.
24. Rothbard AB, Miller K, Lee S, Blank M. Revised cost estimates of Medicaid recipients with serious mental illness and HIV-AIDS. Psychiatr Serv 2009; 60: 974-977.
25. Stensland MD, Jacobson JG, Nyhuis A. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care. J Affect Disord 2007; 101: 187-193.
26. Dardennes R, Thuile J, Friedman S, Guelfi JD. The costs of bipolar disorder. Encephale 2006; 32: 18-25.
27. Guo JJ, Keck PE Jr, Li H, Jang R, Kelton CM. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health 2008; 11: 416-423.
28. Knoth RL, Chen K, Tafesse E. Datapoints: costs associated with the treatment of patients with bipolar disorder in a managed care organization. Psychiatr Serv 2004; 55: 1353.
29. Alvarez Ariza M, Mateos Alvarez R, Berrios GE. A review of the natural course of bipolar disorders (manic-depressive psychosis) in the pre-drug era: review of studies prior to 1950. J Affect Disord 2009; 115: 293-301.
30. Schurhoff F, Bellivier F, Jouvent R et al. Early and late onset bipolar disorders: two different forms of manic-depressive illness? J Affect Disord 2000; 58: 215-221.
31. Lage MJ, Hassan MK. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study. Ann Gen Psychiatry 2009; 8: 7-15.
32. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004; 55: 886-891.
33. Simon GE, Ludman EJ, Bauer MS, Unutzer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006; 63: 500-508.
34. Kessing LV. Gender differences in the phenomenology of bipolar disorder. Bipolar Disord 2004; 6: 421-425.